SCHEMBL22160094

SCHEMBL22160094

CC(C)(C)[Si](O[C@@H]1CC[C@H](C(=O)O)C1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.42
AKR1C1 Q04828 1/20 0.42
S1PR5 Q9H228 5/20 0.37
BACE1 P56817 1/20 0.37
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
GLA P06280 1/20 0.34
ACSL1 P33121 3/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
ELANE P08246 1/20 0.33
CYSLTR2 Q9NS75 1/20 0.32
CYSLTR1 Q9Y271 1/20 0.32
ACSL3 O95573 1/20 0.32
ACSL6 Q9UKU0 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
VCP P55072 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30315459 1.00 AKR1C3 (0.42) AKR1C3AKR1C1S1PR5BACE1NPC1
SCHEMBL5575859 0.92 BTK (0.38) AKR1C3AKR1C1S1PR5BACE1PDE4A
SCHEMBL3939390 0.92 BTK (0.38) AKR1C3AKR1C1S1PR5BACE1PDE4A
SCHEMBL5575853 0.92 BTK (0.38) AKR1C3AKR1C1S1PR5BACE1PDE4A
SCHEMBL1501373 0.92 BACE1 (0.40) AKR1C3AKR1C1S1PR5BACE1NPC1
SCHEMBL10437850 0.92 BACE1 (0.40) AKR1C3AKR1C1S1PR5BACE1NPC1
SCHEMBL21222073 0.90 BACE1 (0.36) AKR1C3AKR1C1S1PR5BACE1
SCHEMBL21222072 0.90 BACE1 (0.36) AKR1C3AKR1C1S1PR5BACE1
SCHEMBL22614223 0.90 BACE1 (0.36) AKR1C3AKR1C1S1PR5BACE1
SCHEMBL28578991 0.89 BACE1 (0.37) AKR1C3AKR1C1S1PR5BACE1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3644992-B1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME LLC (US) 2023-03-29 EP disclosed
US-11149036-B2 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor MSD R&D (CHINA) CO., LTD. (CN) 2021-10-19 US disclosed
US-20200207758-A1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR MERCK SHARP & DOHME CORP. (US) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207758-A1 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR CHRM4, CHRM3, CHRM5 AKR1C3 869/4885AKR1C1 1812/4885S1PR5 652/4885
US-11149036-B2 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor CHRM4, CHRM3, CHRM5 AKR1C3 869/4885AKR1C1 1812/4885S1PR5 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.